查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587499

组织工程市场规模、份额、趋势分析报告：按应用、地区、细分市场预测，2025-2030 年

Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine, Urology), By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

组织工程市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球组织工程市场规模预计将达到431.3亿美元，2025年至2030年复合年增长率预计为14.3%。

心血管疾病、糖尿病和整形外科疾病等慢性疾病的增加增加了对修復或替换受损组织的组织工程解决方案的需求。生物材料、3D 生物列印、干细胞研究和基因编辑技术的进步正在推动组织工程领域的发展，并促进复杂功能组织的发展。

同种异体组织移植技术有效地解决了与自体移植的使用和可近性相关的挑战和限制。此外，旨在将同种异体植入转化为生物植入的植入固定和灭菌等专门程序的进步预计将推动该市场的收益。

组织再生技术因其有效的产品和低排斥率而越来越受欢迎，从而导致再生治疗的增加。目前临床前研究的重点是组织工程血管移植物在心血管手术和治疗的使用。此外，组织工程膀胱现已成功植入患者体外。儘管取得了这些进步，但市场成长仍受到产品开发成本高以及干细胞研究和组织工程产品伦理问题等挑战的阻碍。

组织工程市场报告亮点

  • 由于肌肉骨骼疾病的盛行率不断增加，整形外科、肌肉骨骼和脊椎领域的收益最大，2024 年市场占有率为 59.21%。
  • 北美市场占据主导地位，2024 年销售份额最大，为 51.30%。这是由于人们对干细胞治疗认识的提高、老年人口的增加以及慢性病盛行率的上升。
  • 在市场估计和预测期内，亚太地区的组织工程市场预计复合年增长率为19.04%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章组织工程市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 组织工程市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 应用业务分析

  • 细分仪表板
  • 全球组织工程市场应用变迁分析
  • 2018-2030年全球组织工程市场规模及趋势分析（按应用）
  • 脐带血和细胞库
  • 癌症
  • 胃肠科/妇科
  • 牙科
  • 皮肤和体被
  • 泌尿系统
  • 整形外科、肌肉骨骼、脊柱
  • 神经病学
  • 心血管医学
  • 其他的

第五章区域业务分析

  • 区域仪表板
  • 组织工程市场：2024 年和 2030 年按地区分類的份额
  • 北美洲
    • 北美组织工程市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲组织工程市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 亚太组织工程市场，2018-2030
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲组织工程市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲组织工程市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 公司/竞争对手分类
  • 策略规划
  • 2024年企业定位分析
  • 公司简介/名单
    • Zimmer Biomet Holdings, Inc.
    • AbbVie（Allergan）
    • Becton, Dickinson and Company
    • B. Braun
    • Integra LifeSciences Corporation
    • Organogenesis Holdings Inc.
    • Medtronic
    • ACell, Inc.
    • Athersys, Inc.
    • Tissue Regenix Group plc
    • Stryker Corporation
    • RTI Surgical, Inc.
    • ReproCell, Inc.
    • Baxter International, Inc.
Product Code: 978-1-68038-768-1

Tissue Engineering Market Growth & Trends:

The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient's body. Despite these advancements, the market's growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights:

  • The orthopedics, musculoskeletal, & spine segment held the largest revenue of 59.21% market share in 2024, owing to the increasing prevalence of musculoskeletal disorders.
  • North America dominated the market and accounted for the largest revenue share of 51.30% in 2024, owing to rising awareness of stem cell therapy, the growing geriatric population, and the rising incidence of chronic diseases.
  • The market for tissue engineering in Asia Pacific is estimated to witness the fastest CAGR of 19.04% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tissue Engineering Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in stem cell technology & tissue engineering
      • 3.2.1.2. Rise in number of clinical studies for Tissue Engineering and tissue engineering
      • 3.2.1.3. Increasing tissue engineering research funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product development
      • 3.2.2.2. Ethical concerns related to stem cell research & tissue engineered product
      • 3.2.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
  • 3.3. Tissue Engineering Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Tissue Engineering Market Application Movement Analysis
  • 4.3. Global Tissue Engineering Market Size & Trend Analysis, by Specimen, 2018 to 2030 (USD Million)
  • 4.4. Cord blood & Cell banking
    • 4.4.1. Cord blood & Cell banking market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Cancer
    • 4.5.1. Cancer market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. GI/Gynecology
    • 4.6.1. GI/Gynecology therapy market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Dental
    • 4.7.1. Dental market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Skin & Integumentary
    • 4.8.1. Skin & Integumentary market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Urology
    • 4.9.1. Urology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Orthopedics, Musculoskeletal, & Spine
    • 4.10.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Neurology
    • 4.11.1. Neurology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Cardiology & Vascular
    • 4.12.1. Cardiology & Vascular market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Dashboard
  • 5.2. Tissue Engineering Market: Share By Region, 2024 & 2030
  • 5.3. North America
    • 5.3.1. North America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Sweden Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Norway Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Denmark Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. China Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Japan Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Saudi Arabia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. UAE Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Tissue Engineering Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Zimmer Biomet Holdings, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. AbbVie (Allergan)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Becton, Dickinson and Company
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. B. Braun
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Integra LifeSciences Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Organogenesis Holdings Inc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. ACell, Inc.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Athersys, Inc.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Tissue Regenix Group plc
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Stryker Corporation
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. RTI Surgical, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. ReproCell, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Baxter International, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 12 Germany tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 14 France tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 17 Sweden tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 18 Norway tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 19 Denmark tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 21 APAC tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 22 China tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 23 Japan tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 24 India tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tissue engineering: market outlook
  • Fig. 9 Tissue engineering competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tissue engineering market driver impact
  • Fig. 15 Tissue engineering market restraint impact
  • Fig. 16 Tissue engineering market strategic initiatives analysis
  • Fig. 17 Global tissue engineering market: application movement analysis
  • Fig. 18 Global tissue engineering market: application outlook and key takeaways
  • Fig. 19 Global cord blood & Cell Banking market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 20 Global cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global GI, Gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Global dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global skin & Integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global urology market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 25 Global orthopedics, Musculoskeletal, & Spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global cardiology & Vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global tissue engineering market: regional movement analysis
  • Fig. 30 Global tissue engineering market: regional outlook and key takeaways
  • Fig. 31 Global market share and leading players
  • Fig. 32 North America market, SWOT analysis
  • Fig. 33 Europe market, SWOT analysis
  • Fig. 34 Asia Pacific market, SWOT analysis
  • Fig. 35 Latin America market, SWOT analysis
  • Fig. 36 Middle East & Africa market, SWOT analysis
  • Fig. 37 North America
  • Fig. 38 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Participant categorization- Tissue engineering market
  • Fig. 67 Market position of key market players- Tissue engineering market